Mar 09: Roche and Biogen Idec suspend Ocrelizumab in RA over side ef ...

Mar 08: Vitamin D critical in activating first-line immune defence

Mar 05: Novo Nordisk wins US Approval for somatropin drug

Mar 04: Multimillion EU biorefinery project kicked off

Mar 03: European Commission changes GMO policy: Amflora potato and G ...

Mar 02: Elan finds biomarker to monitor Alzheimer’s plaques

Mar 01: Genetic variants identified for increased risk of coeliac di ...

Feb 26: Avastin slows down advanced ovarian cancer: Phase III study  ...

Feb 25: Basilea in EUR375 million deal with Astellas

Feb 23: Global GMO acreage growth declines

Feb 23: UK invests £200m in high-tech industry

Feb 22: CHMP rejects MAA of Basilea’s/J&J’s ceftobiprole

Feb 19: New method makes vaccines stable at tropical temperatures

Feb 18: Pharming identifies new indication for C1 inhibitor

Feb 17: Consortium invests EUR28m in personalised medicine

Feb 16: Induced pluripotent stem cells not appropriate to study dise ...

Feb 15: Researchers extend genetic code to produce artificial protei ...

Feb 12: Streptococcus vaccine trials a success for Intercell

Feb 11: Boehringer to expand in Asia

Feb 10: Debiopharm licences potential Hepatitis C blockbuster to Nov ...